Exogenous and Endogenous Dendritic Cell-Derived Exosomes: Lessons Learned for Immunotherapy and Disease Pathogenesis

Immune therapeutic exosomes, derived exogenously from dendritic cells (DCs), the ‘directors’ of the immune response, are receiving favorable safety and tolerance profiles in phase I and II clinical trials for a growing number of inflammatory and neoplastic diseases. DC-derived exosomes (EXO), the fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Elashiry, Mahmoud, Elsayed, Ranya, Cutler, Christopher W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750541/
https://www.ncbi.nlm.nih.gov/pubmed/35011677
http://dx.doi.org/10.3390/cells11010115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750541/
https://www.ncbi.nlm.nih.gov/pubmed/35011677
http://dx.doi.org/10.3390/cells11010115

Ejemplares similares